0001837607 2025-01-01 2025-12-31 0001837607 false PRE 14A AEON Biopharma, Inc. <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Equity awards are ordinarily granted in the first-quarter annual process</span><span style="font-family:'Arial','Helvetica','sans-serif';"> and on commencement of employment. </span><span style="font-family:'Arial','Helvetica','sans-serif';">We do not grant awards in anticipation of material nonpublic information</span><span style="font-family:'Arial','Helvetica','sans-serif';"> or </span><span style="font-family:'Arial','Helvetica','sans-serif';">time its release to affect executive compensation.</span><span style="font-family:'Arial','Helvetica','sans-serif';"> If the Compensation Committee knows material nonpublic information when considering a grant, it evaluates whether a delay is appropriate. Option exercise prices use the grant-date closing price on the Exchange, or the preceding trading-day close if the grant date is not a trading day. No 2025 named executive officer option grants occurred during the four-business-day period before or one-business-day period after the specified periodic-report or material-information Form 8-K filings.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Arial','Helvetica','sans-serif';">Equity awards are ordinarily granted in the first-quarter annual process</span><span style="font-family:'Arial','Helvetica','sans-serif';"> and on commencement of employment. </span><span style="font-family:'Arial','Helvetica','sans-serif';">We do not grant awards in anticipation of material nonpublic information</span><span style="font-family:'Arial','Helvetica','sans-serif';"> or </span><span style="font-family:'Arial','Helvetica','sans-serif';">time its release to affect executive compensation.</span><span style="font-family:'Arial','Helvetica','sans-serif';"> If the Compensation Committee knows material nonpublic information when considering a grant, it evaluates whether a delay is appropriate. Option exercise prices use the grant-date closing price on the Exchange, or the preceding trading-day close if the grant date is not a trading day. No 2025 named executive officer option grants occurred during the four-business-day period before or one-business-day period after the specified periodic-report or material-information Form 8-K filings.</span></p> true <span style="font-family:'Arial','Helvetica','sans-serif';">We do not grant awards in anticipation of material nonpublic information</span><span style="font-family:'Arial','Helvetica','sans-serif';"> or </span><span style="font-family:'Arial','Helvetica','sans-serif';">time its release to affect executive compensation.</span> false false